Jeffrey Jensen of Oregon Health & Science University in the U.S. will test the feasibility of using the varicose vein treatment polidocanol in a foam format to close fallopian tubes. The method could be administered by minimally-trained healthcare workers and could be a low-cost, nonsurgical permanent contraceptive method for women in developing countries who want control over their long-term family planning. This project's Phase I research showed that polidocanol foam can block the fallopian tubes of rhesus macaques without causing adverse non-target effects.